StayCurrentMD · PAPS - Optimizing skin antisepsis for neonatal surgery - Sophie Carr
Follow
Video·Published May 2022Older

PAPS - Optimizing skin antisepsis for neonatal surgery - Sophie Carr

With Dr. Sophie Carr & Dr. Rebecca Rentea
Try
Intelligent Search· scoped to surgical site infections · not medical adviceSearch the whole library →
What the experts said14 expert statements · 4 host summaries
Surgical site infections are a costly, yet modifiable source of morbidity, particularly within the neonatal population.
ClinicalSophie Carr
Equivalent data does not yet exist for the neonatal surgical population comparing CHG-IPA to povidone iodine.
EpidemiologicalSophie Carr
The protocol inclusion was limited to general surgery patients with 34 weeks post conceptual age and 1500 grams as the lower age and weight limits.
ClinicalSophie Carr
Either 2% or 0.5% CHG solution was used based on age cutoffs.
ClinicalSophie Carr
Skin integrity was assessed using a validated tool called the neonatal skin condition score.
ClinicalSophie Carr
Implementation of the protocol occurred in February 2020.
ClinicalSophie Carr
A total of 50 patients were included, none of which experienced adverse skin prep outcomes.
ClinicalSophie Carr
8% of patients in the CHG cohort developed SSIs within the 30-day post-op period compared to 14% in the matched retrospective povidone cohort.
EpidemiologicalSophie Carr
A comparison of SSI rates between the CHG versus PI cohort revealed no significant difference.
EpidemiologicalSophie Carr
The majority of cases were class two clean contaminated cases, which is more in keeping with the literature in terms of adult SSI reduction in use of CHG antisepsis.
ClinicalSophie Carr
The protocol was largely modeled off the McGill protocol used in Quebec, Canada, which used a lower age cutoff of 28 weeks gestational age with a lower weight cutoff of 1000 grams.
ClinicalSophie Carr
The project was conducted in conjunction with initiatives including optimizing antibiotic prophylaxis, using adherent draping, and for class two clean contaminated cases, using a clean closure bundle including changing gloves prior to closure.
ClinicalSophie Carr
The decrease in SSI was not statistically significant.
EpidemiologicalSophie Carr
The protocol applied to all general surgery cases that did not have any open exposed mucosa and in which the patient was not allergic to CHG or IPA.
ClinicalSophie Carr
A growing body of evidence in adults suggests that chlorhexidine gluconate and isopropyl alcohol provide superior protection against SSIs than povidone iodine.
Host summarySophie Carr summarizes what Dr. Rebecca Rentea said · not cited in answers
CHG antisepsis is commonly used for invasive non-surgical procedures in NICUs and for prevention of newborn nosocomial infections in developing countries.
Host summarySophie Carr summarizes what Dr. Rebecca Rentea said · not cited in answers
Current product labeling discourages CHG IPA antisepsis in infants under two months of age due to limited safety data and concerns around adverse effects, particularly skin injuries.
Host summarySophie Carr summarizes what Dr. Rebecca Rentea said · not cited in answers
The primary adverse concern is skin reactions with less than 28 weeks gestational age being the primary population affected by those in the literature.
Host summarySophie Carr summarizes what Dr. Rebecca Rentea said · not cited in answers